Clinical Trials Logo

Ischemic Cerebral Infarction clinical trials

View clinical trials related to Ischemic Cerebral Infarction.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT04205578 Not yet recruiting - Ischemic Stroke Clinical Trials

NBP in Patients With Moyamoya Disease of High Risk for Ischemic Cerebrovascular Events

NICE-MMD
Start date: January 2020
Phase: Phase 3
Study type: Interventional

An extracranial-to-intracranial (EC-IC) revascularization is the most widely used treatment to improve cerebral perfusion in patients with moyamoya disease (MMD), and it has been shown to reduce the risk of subsequent stroke and neurological deficit. However, perioperative changes in cerebral hemodynamics can induce fluctuations in cerebral perfusion that may lead to transient or irreversible neurological deficits. Our preliminary single-center study suggests that postoperative intravenous administration of dl-3-n-butylphthalide (NBP) may alleviate perioperative neurological deficits and improve the neurological outcomes after EC-IC revascularization for MMD. This is a multicenter, randomized, double-blind, single-controlled, add-on to standard of care study of NBP in patients with MMD of high risk for ischemic cerebrovascular events after EC-IC revascularization surgery.